Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus.
Explore this paper's citation graph
Summary
There is no significant difference in the risk of MACE between DPP-4 inhibitors and placebo groups, and type 2 diabetes population as well as the population at high cardiovascular risk is surveyed.
- Type
- article
- Published
- 2016-06-01
- Cited by
- 13
- References
- 31
- OpenAlex
- https://openalex.org/W27321333
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:13066426
Keywords
Socialization, Organizational commitment, Public relations, Psychology, Social psychology
References
- Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.
- Cochrane Handbook for Systematic Reviews of Interventions
- Operating characteristics of a rank correlation test for publication bias.
- Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study.
- Dipeptidyl Peptidase‐4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
- Relationship between blood glucose level and mortality in Type 2 diabetes mellitus: a systematic review
- Chronic DPP-4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
- Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project
- Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
- Standards of Medical Care in Diabetes: Response to Power
- Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
- Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes.
- Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
- Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
- Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes
- Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
- NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects
- Measuring inconsistency in meta-analyses
- Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
Cited by
- Cardiovascular disease prevention strategies for type 2 diabetes mellitus
- Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
- Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study
- The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes
- Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
- Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors.
- Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control
- Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized
- Effect of Dipeptidyl Peptidase-4 Inhibitors vs. Metformin on Major Cardiovascular Events Using Spontaneous Reporting System and Real-World Database Study
- Safety and cardiometabolic efficacy of novel antidiabetic drugs
- Revisiting the Cardiorenal Safety of Sitagliptin in Type 2 Diabetes Mellitus: A Literature Review.
- Cardiovascular Events and Heart Failure in Patients With Type 2 Diabetes Treated With Dipeptidyl Peptidase-4 Inhibitors: A Meta-Analysis
- Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study.
Related papers
- Organizational Commitment: A Comparison of American, Japanese, and Korean Employees
- The Relationship between Organizational Socialization and Organizational Commitment among the University of Orumiyeh Personnel
- The Influence of Organizational Culture and Organizational Commitment on Performance of Employees (Case Study: Non-Educator Employees at Widyatama University)
- Personal Values and Organizational Commitment among Administrative Employees of a Public University
- THE INFLUENCE OF ORGANIZATIONAL CULTURE AND ORGANIZATIONAL COMMITMENT ON PERFORMANCE OF EMPLOYEES (Case Study : Employees Non Educative Widyatama University)
- The Effects of the Organizational Socialization Education Program on Job Satisfaction, Organizational Commitment and Turnover Intention of New Nurses
- The Effect of Organizational Justice Perception on Organizational Commitment among Healthcare Sector Employees
- 카지노 종사원의 조직사회화가 조직유효성에 미치는 영향에 관한 연구: 상사신뢰의 매개효과